Bausch Health Companies BHC Debt issued (Note 13)
Debt issued (Note 13) at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's debt issued (note 13).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bausch Health Companies's debt issued (note 13)?
- Bausch Health Companies (BHC) reported debt issued (note 13) of $2.8B in Q1 2026.
- How has Bausch Health Companies's debt issued (note 13) changed year-over-year?
- Bausch Health Companies's debt issued (note 13) increased by 5504.0% year-over-year, from $50M to $2.8B.
- What is the long-term trend for Bausch Health Companies's debt issued (note 13)?
- Over 4 years (2021 to 2025), Bausch Health Companies's debt issued (note 13) has grown at a 49.7% compound annual growth rate (CAGR), from $2.1B to $10.56B.